American trypanosomiasis is a parasitic zoonosis that occurs throughout Latin America. The etiological agent, Trypanosoma cruzi, is able to infect almost all tissues of its mammalian hosts and spreads in the environment in multifarious transmission cycles that may or not be connected. This biological plasticity, which is probably the result of the considerable heterogeneity of the taxon, exemplifies a successful adaptation of a parasite resulting in distinct outcomes of infection and a complex epidemiological pattern. In the 1990s, most endemic countries strengthened national control programs to interrupt the transmission of this parasite to humans. However, many obstacles remain to the effective control of the disease. Current knowledge of the different components involved in elaborate system that is American trypanosomiasis (the protozoan parasite T. cruzi, vectors Triatominae and the many reservoirs of infection), as well as the interactions existing within the system, is still incomplete. The Triatominae probably evolve from predatory reduvids in response to the availability of vertebrate food source. However, the basic mechanisms of adaptation of some of them to artificial ecotopes remain poorly understood. Nevertheless, these adaptations seem to be associated with a behavioral plasticity, a reduction in the genetic repertoire and increasing developmental instability.
A survey of natural ecotopes of Triatoma infestans dark morph and other triatomine sylvatic species was performed in an uninhabited area of the Bolivian Chaco. Among the 321 triatomines collected by light trapping, only 4 T. infestans dark morph specimens were identified. Predominant flying species were T. guasayana and T. sordida group 2 (51.7% and 37.1% of capture, respectively). The same species prevailed in terrestrial and epiphytic bromeliads where scarce T. infestans dark morph nymphal instars were also detected. In parrot nests T. delpontei prevailed broadly over other species (90.2% of the capture) and only 4 T. infestans dark morph adults were collected. In contrast, T. infestans dark morph was the predominant species captured in hollow trees (46.0% of the total collected). The abundance of immature forms (88.2% of the collection) shows that hollow trees constitute a favourable ecotope for this species. Of the 421 trees investigated, 33.7% were positive for triatomines. T. infestans dark morph, found inside 15.0% of them, also had higher apparent density than other species (average number of T. infestans in positive trees, 2.0 +/- 1.6 vs 1.3 +/- 0.6 for other species). Light trapping seems to be an efficient method to sample the T. sordida-T. guasayana complex in that it shows a similar distribution to that observed in natural ecotopes; however, this method is ineffective for the assessment of the local abundance of T. infestans dark morph.
Just over 100 autochthonous cases of Chagas disease are reported from the Brazilian Amazon Basin. Panstrongylus geniculatus (Latreille) occurs throughout the region and is the known vector of Trypanosoma cruzi, principal zymodeme 3 (Z3) to the armadillo Dasypus novemcinctus. In the small riverine community of Furo do Rio Pau Grande, pigsties adjoining houses were heavily infested with P. geniculatus, which repeatedly attacked local inhabitants. Palm trees in the immediate vicinity were also infested. T. cruzi principal zymodeme 1 (Z1) was isolated from P. geniculatus, domestic pigs, and opossums, but no human infections were detected. The threat of endemic Chagas disease to the Amazon Basin from either domiciliation of local silvatic triatomine species, or from migration of domestic vectors, demands a program of vigilance and plans of action to eliminate household triatomine colonies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.